Article Text

Download PDFPDF
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic
  1. Donya Mohebali,
  2. Michelle M Kittleson
  1. Department of Cardiology, Smidt Heart Institute, Cedars Sinai Heart Institute, Los Angeles, California, USA
  1. Correspondence to Dr Michelle M Kittleson, Department of Cardiology, Smidt Heart Institute, Cedars Sinai Heart Inst, Los Angeles, CA 90048, USA; michelle.kittleson{at}


The incidence of heart failure (HF) remains high and patients with HF are at risk for frequent hospitalisations. Remote monitoring technologies may provide early indications of HF decompensation and potentially allow for optimisation of therapy to prevent HF hospitalisations. The need for reliable remote monitoring technology has never been greater as the COVID-19 pandemic has led to the rapid expansion of a new mode of healthcare delivery: the virtual visit. With the convergence of remote monitoring technologies and reliable method of remote healthcare delivery, an understanding of the role of both in the management of patients with HF is critical. In this review, we outline the evidence on current remote monitoring technologies in patients with HF and highlight how these advances may benefit patients in the context of the current pandemic.

  • heart failure
  • systolic
  • cardiomyopathy
  • dilated
  • telemedicine

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @N/A, @MKittlesonMD

  • Contributors The manuscript has been read and approved by all named authors and all authors contributed equally. The order of authors listed in the manuscript has been approved by all authors.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.